• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性肿瘤患者心包积液的外科治疗。剑突下开窗术与心包切除术的比较。

Surgical management of pericardial effusion in patients with malignancies. Comparison of subxiphoid window versus pericardiectomy.

作者信息

Park J S, Rentschler R, Wilbur D

机构信息

Department of Internal Medicine, Loma Linda University Medical Center, California 92350.

出版信息

Cancer. 1991 Jan 1;67(1):76-80. doi: 10.1002/1097-0142(19910101)67:1<76::aid-cncr2820670115>3.0.co;2-6.

DOI:10.1002/1097-0142(19910101)67:1<76::aid-cncr2820670115>3.0.co;2-6
PMID:1702345
Abstract

There is a lack of consensus regarding optimal surgical management of symptomatic pericardial effusions in patients with malignancies. Subxiphoid pericardial window formation (subxiphoid pericardial drainage) has been considered a safe and effective method for diagnostic and therapeutic purposes. To ensure adequate drainage, many surgeons prefer the formation of a larger pericardial window by performing either an anterior thoracotomy or a partial/total pericardiectomy. To evaluate the efficacy of these methods for palliation of symptomatic pericardial effusion in patients with malignancy, 28 consecutive pericardial surgery cases involving patients with malignancy were retrospectively analyzed. Ten patients (Group 1) had subxiphoid window formation, whereas 18 patients (Group 2) had partial or total pericardiectomy or pericardial window formation by anterior thoracotomy. There was no statistically significant difference (P = 0.22) in the survival rates between these two groups. A median survival time of 2.67 months (range, 0.43 to 26.6 months) was observed in Group 1 versus 1.23 months (range, 0.03 to 10.83 months) in Group 2. However, a statistically significant difference (P less than or equal to 0.02) in postoperative morbidity was observed between the two groups: 67% in Group 2 versus 10% in Group 1. Because of lower morbidity, subxiphoid pericardial window formation is recommended by this study as the preferred surgical method for palliation of symptomatic pericardial effusion in patients with malignancy.

摘要

对于恶性肿瘤患者有症状心包积液的最佳手术管理,目前尚无共识。剑突下心包开窗术(剑突下心包引流)被认为是一种用于诊断和治疗目的的安全有效方法。为确保充分引流,许多外科医生倾向于通过开胸手术或部分/全心包切除术来形成更大的心包开窗。为评估这些方法对恶性肿瘤患者有症状心包积液的缓解效果,对28例连续的恶性肿瘤患者心包手术病例进行了回顾性分析。10例患者(第1组)进行了剑突下心包开窗术,而18例患者(第2组)进行了部分或全心包切除术或通过开胸手术进行心包开窗术。两组之间的生存率无统计学显著差异(P = 0.22)。第1组的中位生存时间为2.67个月(范围为0.43至26.6个月),而第2组为1.23个月(范围为0.03至10.83个月)。然而,两组术后发病率存在统计学显著差异(P≤0.02):第2组为67%,第1组为10%。由于发病率较低,本研究推荐剑突下心包开窗术作为恶性肿瘤患者有症状心包积液缓解的首选手术方法。

相似文献

1
Surgical management of pericardial effusion in patients with malignancies. Comparison of subxiphoid window versus pericardiectomy.恶性肿瘤患者心包积液的外科治疗。剑突下开窗术与心包切除术的比较。
Cancer. 1991 Jan 1;67(1):76-80. doi: 10.1002/1097-0142(19910101)67:1<76::aid-cncr2820670115>3.0.co;2-6.
2
Mid-Term Efficacy of Subxiphoid Versus Transpleural Pericardial Window for Pericardial Effusion.剑突下与经胸膜心包开窗术治疗心包积液的中期疗效
J Surg Res. 2020 Aug;252:9-15. doi: 10.1016/j.jss.2020.01.014. Epub 2020 Mar 23.
3
Eleven years' experience with pericardial-peritoneal window in the management of malignant and benign pericardial effusions.心包-腹腔开窗术治疗恶性和良性心包积液11年的经验。
Ann Surg Oncol. 1995 Mar;2(2):165-9. doi: 10.1007/BF02303633.
4
Subxiphoid pericardial window for pericardial effusive disease.用于心包积液性疾病的心包剑突下开窗术
J Cardiovasc Surg (Torino). 1989 Sep-Oct;30(5):768-73.
5
Contemporary outcomes after pericardial window surgery: impact of operative technique.心包开窗术后的当代疗效:手术技术的影响
J Cardiothorac Surg. 2016 Apr 26;11(1):73. doi: 10.1186/s13019-016-0466-3.
6
Subxiphoid pericardial window for pericardial effusion in end-stage renal disease.剑突下心包开窗术用于终末期肾病的心包积液
Am J Kidney Dis. 1996 May;27(5):664-7. doi: 10.1016/s0272-6386(96)90100-6.
7
Pericardioperitoneal shunt: an alternative treatment for malignant pericardial effusion.心包腹膜分流术:恶性心包积液的一种替代治疗方法。
Ann Thorac Surg. 1994 Feb;57(2):289-92. doi: 10.1016/0003-4975(94)90985-7.
8
Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.影响有症状心包积液患者手术干预后生存率的危险因素。
Interact Cardiovasc Thorac Surg. 2013 Apr;16(4):495-500. doi: 10.1093/icvts/ivs491. Epub 2012 Dec 18.
9
Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy.影响接受剑突下心包造口术的心包积液患者生存的危险因素。
Chest. 2003 Jul;124(1):242-6. doi: 10.1378/chest.124.1.242.
10
Pericardial drainage: subxiphoid vs. transthoracic approach.心包引流:剑突下与经胸入路
Eur J Cardiothorac Surg. 1991;5(2):99-103; discussion 104. doi: 10.1016/1010-7940(91)90007-7.

引用本文的文献

1
Surgical Management Strategies for Pericardial Effusion-A Systematic Review.心包积液的外科治疗策略——一项系统评价
J Clin Med. 2025 Jul 14;14(14):4985. doi: 10.3390/jcm14144985.
2
Long-Term Outcomes after Video-Assisted Thoracoscopic Pericardiectomy for Pericardial Effusion.电视辅助胸腔镜下心包切除术治疗心包积液的长期预后
Ann Thorac Cardiovasc Surg. 2017 Dec 20;23(6):304-308. doi: 10.5761/atcs.oa.17-00046. Epub 2017 Aug 9.
3
Performance, pain, and quality of life on use of central venous catheter for management of pericardial effusions in patients undergoing coronary artery bypass graft surgery.
冠状动脉搭桥手术患者使用中心静脉导管治疗心包积液时的性能、疼痛及生活质量
J Pain Res. 2016 Oct 31;9:887-892. doi: 10.2147/JPR.S116483. eCollection 2016.
4
Clinical experience with pericardiocentesis and extended drainage in a population with a high prevalence of HIV.在艾滋病毒高流行人群中进行心包穿刺术和延长引流的临床经验。
Neth Heart J. 2002 Oct;10(10):399-406.
5
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811).一项关于心包内注射博来霉素治疗肺癌所致恶性心包积液的随机试验(JCOG9811)。
Br J Cancer. 2009 Feb 10;100(3):464-9. doi: 10.1038/sj.bjc.6604866. Epub 2009 Jan 20.
6
Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients.实体恶性肿瘤患者心包引流治疗恶性心包积液的预后因素
Med Oncol. 2007;24(4):425-30. doi: 10.1007/s12032-007-0033-9.
7
Successful treatment of malignant pericardial effusion, using weekly paclitaxel, in a patient with breast cancer.一名乳腺癌患者采用每周一次紫杉醇治疗恶性心包积液取得成功。
Int J Clin Oncol. 2006 Oct;11(5):412-5. doi: 10.1007/s10147-006-0593-2.
8
Percutaneous treatment in patients presenting with malignant cardiac tamponade.恶性心脏压塞患者的经皮治疗。
Eur Radiol. 2005 Sep;15(9):2000-9. doi: 10.1007/s00330-004-2611-y. Epub 2005 Jan 21.
9
Occult cardiac lymphoma presenting with cardiac tamponade.隐匿性心脏淋巴瘤伴心脏压塞。
Tex Heart Inst J. 2003;30(1):62-4.
10
Pericardial effusion in patients with cancer: outcome with contemporary management strategies.癌症患者的心包积液:当代管理策略的结局
Heart. 1996 Jan;75(1):67-71. doi: 10.1136/hrt.75.1.67.